Ansaldi F - Search Results

1

Relationship between laboratory parameters and intensive care unit stay post-liver transplantation: proposal of a model.

Sumberaz A, Centenaro M, Ansaldi F, Ancarani AO, Andorno E, Icardi G, Testino G. Sumberaz A, et al. Among authors: ansaldi f. Transplant Proc. 2007 Jul-Aug;39(6):1868-70. doi: 10.1016/j.transproceed.2007.05.080. Transplant Proc. 2007. PMID: 17692636

2

Gastric chief cell mass in duodenal ulcer.

Perasso A, Testino G, Ansaldi F. Perasso A, et al. Among authors: ansaldi f. Acta Gastroenterol Latinoam. 1993;23(1):5-11. Acta Gastroenterol Latinoam. 1993. PMID: 8237265

3

Long-term therapy with interferon in anti-HCV positive chronic hepatitis: is it conceivable?

Perasso A, Testino G, Sumberaz A, Ansaldi F. Perasso A, et al. Among authors: ansaldi f. Minerva Med. 1996 Mar;87(3):69-74. Minerva Med. 1996. PMID: 8668290

4

r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.

Perasso A, Testino G, Ansaldi F, Venturino V, Icardi GC. Perasso A, et al. Among authors: ansaldi f. Hepatology. 1999 Jan;29(1):297-8. doi: 10.1002/hep.510290135. Hepatology. 1999. PMID: 9935339 Clinical Trial. No abstract available.

5

[Molecular typing technics applied to the epidemiology of hepatitis C virus infection].

Icardi G, Bruzzone BM, Ansaldi F, Cresta E, Crovari P. Icardi G, et al. Among authors: ansaldi f. Ann Ig. 1999 Nov-Dec;11(6):511-8. Ann Ig. 1999. PMID: 10596445 Italian. No abstract available.

6

Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping.

Ansaldi F, Torre F, Bruzzone BM, Picciotto A, Crovari P, Icardi G. Ansaldi F, et al. J Med Virol. 2001 Jan;63(1):17-21. J Med Virol. 2001. PMID: 11130882

7

Identification of key mutations in HIV reverse transcriptase gene can influence the clinical outcome of HAART.

Setti M, Bruzzone B, Ansaldi F, Borrelli P, Indiveri F, Icardi G. Setti M, et al. Among authors: ansaldi f. J Med Virol. 2001 Jul;64(3):199-206. doi: 10.1002/jmv.1037. J Med Virol. 2001. PMID: 11424105

8

Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.

Icardi G, Ansaldi F, Bruzzone BM, Durando P, Lee S, de Luigi C, Crovari P. Icardi G, et al. Among authors: ansaldi f. J Clin Microbiol. 2001 Sep;39(9):3110-4. doi: 10.1128/JCM.39.9.3110-3114.2001. J Clin Microbiol. 2001. PMID: 11526137 Free PMC article.

9

Antiviral activity of amantadine in elderly patients with chronic hepatitis C.

Torre F, Campo N, Giusto R, Ansaldi F, Icardi GC, Picciotto A. Torre F, et al. Among authors: ansaldi f. Gerontology. 2001 Nov-Dec;47(6):330-3. doi: 10.1159/000052823. Gerontology. 2001. PMID: 11721147 Clinical Trial.

10

Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.

Testino G, Ansaldi F, Andorno E, Ravetti GL, Ferro C, De Iaco F, Icardi G, Valente U. Testino G, et al. Among authors: ansaldi f. Hepatogastroenterology. 2002 Nov-Dec;49(48):1636-8. Hepatogastroenterology. 2002. PMID: 12397752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters